Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
10/2014
10/02/2014US20140296343 Non-peptide bdnf neurotrophin mimetics
10/02/2014US20140296256 Plasminogen activator inhibitor-1 inhibitor
10/02/2014US20140296251 Multifunctional quinoline derivatives as anti-neurodegenerative agents
10/02/2014US20140296236 Quinolines as fgfr kinase modulators
10/02/2014US20140296228 Inhibitors of human immunodeficiency virus replication
10/02/2014US20140296215 Cyanoquinoline Compounds Having Activity in Correcting Mutant-Cftr Processing and Increasing Ion Transport and Uses Thereof
10/02/2014US20140296212 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
10/01/2014EP2783688A1 Pharmaceutical tablets of crystalline type ii aripiprazole
09/2014
09/30/2014US8846937 Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
09/30/2014US8846924 Sulfonamide derivatives of polycyclic dyes used for analytical applications
09/30/2014US8846864 Purification tags of synthetic peptides and proteins
09/30/2014US8846707 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein
09/30/2014US8846291 Resist composition, method of forming resist pattern, and new compound
09/25/2014WO2014147611A1 Quinolines derivatives as novel anticancer agents
09/25/2014US20140288119 Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
09/25/2014US20140288059 Therapeutic compositions and methods
09/24/2014EP2780323A1 Process for the preparation of a quinoline carboxylic acid
09/23/2014US8841321 Quinoline derivatives as antibacterial agents
09/23/2014CA2782347C Quinoline amide m1 receptor positive allosteric modulators
09/23/2014CA2596393C 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions
09/18/2014WO2014145723A1 Base addition salts of nitroxoline and uses thereof
09/18/2014WO2014145715A1 Metabolites of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide
09/18/2014WO2014145693A1 Metabolites of n-[3-fluoro-4-({ 6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
09/18/2014WO2014144197A1 Stereodynamic chemosensors
09/18/2014WO2014140076A1 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
09/18/2014WO2014139963A1 Cosmetic compositions with tricyclodecane amides
09/18/2014WO2014139485A1 A method for the preparation of 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-l-hydroxyethyl]- 8-hydroxy-(1h)-quinolin-2-one (indacaterol)
09/18/2014WO2014138833A1 Compounds, use, pharmaceutical composition for inhibiting reductase in microorganisms, inha binder and method for obtaining inha binders
09/18/2014US20140275548 Substituted naphthyridine and quinoline compounds as mao inhibitors
09/18/2014US20140275165 COMPOUNDS THAT INHIBIT NFkB AND BACE1 ACTIVITY
09/18/2014US20140275108 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
09/18/2014US20140275088 Small molecule malarial aldolase-trap enhancers and glideosome inhibitors
09/18/2014US20140275060 Compounds for the treatment of neurologic disorders
09/18/2014US20140271878 Crystals of laquinimod sodium and improved process for the manufacture thereof
09/17/2014EP2776397A1 Quinolines as fgfr kinase modulators
09/16/2014US8835639 Process for making modulators of cystic fibrosis transmembrane conductance regulator
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835461 Substituted 3-hydroxy-4-pyridone derivative
09/16/2014US8835458 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells
09/16/2014US8835022 Metal complex compound and organic light emitting diode device including the same
09/16/2014CA2750864C Bis-aryl amide compounds and methods of use
09/16/2014CA2570680C Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions
09/12/2014WO2014138375A1 Antibiotic conjugates linked with steroid drugs
09/12/2014WO2014138359A1 Steroid antibiotic conjugates
09/12/2014WO2014138350A1 Antibiotic conjugates directly linked with steroid drugs
09/12/2014WO2014135096A1 Ivacaftor preparation method and intermediate thereof
09/11/2014US20140256948 3-cyano-quinoline derivatives with antiproliferative activity
09/11/2014US20140256938 Process for Preparing Quinoline Derivatives
09/11/2014US20140256770 Process for making modulators of cystic fibrosis transmembrane conductance regulator
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
09/11/2014US20140256549 Labile esters of agrochemicals for controlled release and reduction of off-site movement
09/11/2014US20140255483 Pharmaceutical composition and administrations thereof
09/10/2014EP2773619A1 New aryl-quinoline derivatives
09/09/2014US8829204 Modulators of ATP-binding cassette transporters
09/09/2014US8829196 TRPA1 antagonists
09/09/2014US8829186 Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof
09/09/2014US8829034 Compounds which modulate the CB2 receptor
09/09/2014US8829002 Substituted methyl amines, serotonin 5-HT6 receptor antagonists, methods for production and use thereof
09/09/2014US8828981 Progesterone for the treatment or prevention of spontaneous preterm birth
09/04/2014WO2009144742A3 An improved process for preparing montelukast and salts thereof
09/04/2014US20140249148 Selective hdac3 inhibitors
09/04/2014US20140249144 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
09/03/2014EP2771323A2 A bis-quinaldine compound and a process for preparing the same
09/02/2014USRE45108 Quinolone compound and pharmaceutical composition
09/02/2014US8822691 Pesticidal carboxamides
09/02/2014US8822467 Biaryl oxyacetic acid compounds
09/02/2014US8822452 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
09/02/2014US8822414 Heterocyclic compounds suitable for the treatment of dyslipidemia
09/02/2014US8822043 Organic compound and organic light-emitting device
08/2014
08/28/2014WO2014130612A1 Therapeutic compounds and uses thereof
08/28/2014US20140243532 Novel precursors of glutamate derivatives
08/28/2014US20140243345 Selective hdac3 inhibitors
08/28/2014US20140243321 Bioorthogonal monomers capable of dimerizing and targeting bromodomains, and methods of using same
08/28/2014US20140243314 Quinolinone carboxamide inhibitors of endothelial lipase
08/28/2014US20140243289 Prodrugs of modulators of abc transporters
08/28/2014US20140242172 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/27/2014EP2769976A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof
08/27/2014EP2768805A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
08/27/2014EP2768796A1 Process for preparing quinoline derivatives
08/26/2014US8815902 Tetrahydroquinoline amide M1 receptor positive allosteric modulators
08/26/2014US8815901 Quinoline carboxamide derivatives as protein tyrosine kinase inhibitors
08/26/2014US8815893 Hetarylaminonaphthyridines
08/26/2014US8815849 Hetero-bicyclic derivatives as HCV inhibitors
08/26/2014US8815241 Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
08/21/2014WO2014127335A1 Therapeutic compounds and uses thereof
08/21/2014WO2014127214A1 Therapeutic compounds and uses thereof
08/21/2014WO2014125970A1 Novel fused polycyclic compound and organic light emitting element including the same
08/21/2014US20140235857 Intermediate for manufacture of polymerizable compound and process for manufacture thereof
08/21/2014US20140235548 Compositions and methods for jamm protein inhibition
08/20/2014EP2766343A1 Compounds that trap alpha-oxoaldehydes and alpha-beta-unsaturated aldehydes, meta-compounds containing such compounds, and use of said compounds in treating illnesses related to the accumulation of ages and ales
08/19/2014US8809584 N-substituted-N-phenylethylsulfonamides for the identification of biological and pharmacological activity
08/19/2014US8809537 N-ethyl-4-hydroxyl-1-methyl-5-(methyl(2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide
08/19/2014US8809535 Substituted pyridines having herbicidal action
08/19/2014US8809369 Tetrahydroquinoline derivatives
08/19/2014US8809368 Compounds affecting gap junction activity
08/19/2014CA2654801C Quinolinone derivatives and their pharmaceutical compositions
08/14/2014WO2014124220A1 Reduced sodium food product
08/14/2014WO2014124214A1 Reduced sodium food products
08/14/2014WO2014124207A1 Reduced sodium food products
08/14/2014WO2014124193A1 Reduced sodium food products
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 277